215 related articles for article (PubMed ID: 21900200)
1. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.
Lucioni M; Novara F; Fiandrino G; Riboni R; Fanoni D; Arra M; Venegoni L; Nicola M; Dallera E; Arcaini L; Onida F; Vezzoli P; Travaglino E; Boveri E; Zuffardi O; Paulli M; Berti E
Blood; 2011 Oct; 118(17):4591-4. PubMed ID: 21900200
[TBL] [Abstract][Full Text] [Related]
2. Narrowing down the common deleted region of 5q to 6.0 Mb in blastic plasmacytoid dendritic cell neoplasms.
Fu Y; Fesler M; Mahmud G; Bernreuter K; Jia D; Batanian JR
Cancer Genet; 2013; 206(7-8):293-8. PubMed ID: 24042168
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.
Wiesner T; Obenauf AC; Cota C; Fried I; Speicher MR; Cerroni L
J Invest Dermatol; 2010 Apr; 130(4):1152-7. PubMed ID: 19924135
[TBL] [Abstract][Full Text] [Related]
5. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events.
Tang Z; Li Y; Wang W; Yin CC; Tang G; Aung PP; Hu S; Lu X; Toruner GA; Medeiros LJ; Khoury JD
Leuk Res; 2018 Oct; 73():86-94. PubMed ID: 30248580
[TBL] [Abstract][Full Text] [Related]
6. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
[TBL] [Abstract][Full Text] [Related]
7. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
Cheng W; Yu TT; Tang AP; He Young K; Yu L
Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
[TBL] [Abstract][Full Text] [Related]
8. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
9. Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.
Petrella T; Hervé G; Bonnotte B; Girodon F; Carlson JA; Bour JB; Lebon P; Mugneret F; Callier P
Am J Dermatopathol; 2012 Aug; 34(6):626-31. PubMed ID: 22534638
[TBL] [Abstract][Full Text] [Related]
10. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
11. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
[TBL] [Abstract][Full Text] [Related]
12. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
[TBL] [Abstract][Full Text] [Related]
13. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
[TBL] [Abstract][Full Text] [Related]
14. A case report: Blastic plasmacytoid dendritic cell neoplasm is misdiagnosed as breast infiltrating ductal carcinoma.
Chen KC; Su TC; Chen DR; Liou JH
Int J Surg Pathol; 2015 Feb; 23(1):84-8. PubMed ID: 25297609
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review.
Kim MJ; Nasr A; Kabir B; de Nanassy J; Tang K; Menzies-Toman D; Johnston D; El Demellawy D
J Pediatr Hematol Oncol; 2017 Oct; 39(7):528-537. PubMed ID: 28906324
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm.
Lim D; Goodman H; Rademaker M; Lamont D; Yung A
Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
Shi Y; Wang E
Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
[TBL] [Abstract][Full Text] [Related]
19. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
Zhang X; Sun J; Yang M; Wang L; Jin J
Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
[TBL] [Abstract][Full Text] [Related]
20. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.
Dang X; Zhou D; Meng L; Bi L
J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
